News on Lipodystrophy from BioPortfolio.com http://www.BioPortfolio.com Consolidated Lipodystrophy news from BioPortfolio.com Wed, 10 Feb 2010 07:36:58 GMT en Theratechnologies reports that the FDA will reschedule for administrative reasons the Advisory Committee meetihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007076&HITNO=0&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007076&THISHREF=http://c.moreover.com/click/here.pl%3fz2521000942%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007076&HITNO=0&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007076&THISHREF=http://c.moreover.com/click/here.pl%3fz2521000942%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: FDA Review of HIV Lipodystrophy Drug Is Delayedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967133&HITNO=1&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967133&THISHREF=http://c.moreover.com/click/here.pl%3fz2499454665%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967133&HITNO=1&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967133&THISHREF=http://c.moreover.com/click/here.pl%3fz2499454665%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAIDSmeds: Theratechnologies Inc. (TH.TO) Reports That the FDA Will Reschedule for Administrative Reasons the Advisory Cohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959556&HITNO=2&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959556&THISHREF=http://c.moreover.com/click/here.pl%3fz2495803611%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959556&HITNO=2&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959556&THISHREF=http://c.moreover.com/click/here.pl%3fz2495803611%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: Theratechnologies Reports That the FDA Will Reschedule for Administrative Reasons the Advisory Committee Meetihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958087&HITNO=3&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958087&THISHREF=http://c.moreover.com/click/here.pl%3fz2495217487%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958087&HITNO=3&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958087&THISHREF=http://c.moreover.com/click/here.pl%3fz2495217487%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Theratechnologies Reports That the FDA Will Reschedule for Administrative Reasons the Advisory Committee Meetihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958060&HITNO=4&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958060&THISHREF=http://c.moreover.com/click/here.pl%3fz2495207370%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958060&HITNO=4&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958060&THISHREF=http://c.moreover.com/click/here.pl%3fz2495207370%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Theratechnologies Reports Date for FDA Advisory Committee Review of the Tesamorelin New Drug Applicationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954166&HITNO=5&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954166&THISHREF=http://c.moreover.com/click/here.pl%3fz2492541592%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954166&HITNO=5&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954166&THISHREF=http://c.moreover.com/click/here.pl%3fz2492541592%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: Theratechnologies reports date for FDA Advisory Committeehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942757&HITNO=6&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942757&THISHREF=http://c.moreover.com/click/here.pl%3fz2485862545%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942757&HITNO=6&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942757&THISHREF=http://c.moreover.com/click/here.pl%3fz2485862545%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Theratechnologies Reports Date for FDA Advisory Committee Review of the Tesamorelin New Drug Applicationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3924905&HITNO=7&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3924905&THISHREF=http://c.moreover.com/click/here.pl%3fz2477360223%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3924905&HITNO=7&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3924905&THISHREF=http://c.moreover.com/click/here.pl%3fz2477360223%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Theratechnologies Reports Date for FDA Advisory Committee Review of the Tesamorelin New Drug Applicationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923445&HITNO=8&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923445&THISHREF=http://c.moreover.com/click/here.pl%3fz2476532415%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923445&HITNO=8&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923445&THISHREF=http://c.moreover.com/click/here.pl%3fz2476532415%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Theratechnologies Reports Date for FDA Advisory Committee Review of the Tesamorelin New Drug Applicationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923433&HITNO=9&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923433&THISHREF=http://c.moreover.com/click/here.pl%3fz2476524894%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923433&HITNO=9&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923433&THISHREF=http://c.moreover.com/click/here.pl%3fz2476524894%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEuroInvestor.co.uk: Theratechnologies Reports Date for FDA Advisory Committee Review of the Tesamorelin New Drug Applicationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923413&HITNO=10&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923413&THISHREF=http://c.moreover.com/click/here.pl%3fz2476503000%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923413&HITNO=10&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923413&THISHREF=http://c.moreover.com/click/here.pl%3fz2476503000%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Theratechnologies Reports Date for FDA Advisory Committee Review of the Tesamorelin New Drug Applicationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923412&HITNO=11&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923412&THISHREF=http://c.moreover.com/click/here.pl%3fz2476502732%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923412&HITNO=11&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923412&THISHREF=http://c.moreover.com/click/here.pl%3fz2476502732%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Theratechnologies Reports Date for FDA Advisory Committee Review of the Tesamorelin New Drug Applicationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923312&HITNO=12&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923312&THISHREF=http://c.moreover.com/click/here.pl%3fz2476476903%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923312&HITNO=12&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923312&THISHREF=http://c.moreover.com/click/here.pl%3fz2476476903%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Theratechnologies Reports Date for FDA Advisory Committee Review of the Tesamorelin New Drug Applicationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923186&HITNO=13&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923186&THISHREF=http://c.moreover.com/click/here.pl%3fz2476390272%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923186&HITNO=13&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923186&THISHREF=http://c.moreover.com/click/here.pl%3fz2476390272%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Theratechnologies Reports Date for FDA Advisory Committee Review of the Tesamorelin New Drug Applicationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923185&HITNO=14&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923185&THISHREF=http://c.moreover.com/click/here.pl%3fz2476390077%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3923185&HITNO=14&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lipodystrophy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3923185&THISHREF=http://c.moreover.com/click/here.pl%3fz2476390077%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: